Primary source: Candid Health, “Introducing Candid AgentKits: Agentic RCM solutions that eliminate work,” November 12, 2026. The same item is on the Candid newsroom. The product page is candidhealth.com/agentkits.
On November 12, 2026, Candid launched AgentKits, and the Denials AgentKit is the one you can turn on today. If the claim already lives in a billing system you are not replacing, that is the product. It works the denial, then hands the exception back to the biller in the tool they already use. Eligibility waits until early 2027.
Candid’s touchless claim rate, company-reported. The November 12 post defines it as claims submitted and adjudicated correctly the first time with no manual work. The same post says the platform is trusted by over 200 healthcare organizations, after seven years of building it. That rate belongs to the platform. It is not a Denials AgentKit result.
The post is dated November 12, 2026, and the newsroom lists it the same day. Candid calls AgentKits a suite that combines deterministic rules, agents, and insights to resolve and prevent issues inside an existing billing system. No rip-and-replace is required. Each kit targets one workflow.
| The November 12 launch says | The launch does not say |
|---|---|
| The Denials AgentKit is available now. It investigates, resolves, and prevents denials, using payer phone calls, eligibility checks, and policy analysis. It then prepares appeals, handles write-offs, and routes exceptions to billers. | A price, an overturn rate, a recovered dollar, a cycle time, or a named customer for the kit. |
| The Eligibility AgentKit is coming in early 2027. It confirms coverage, handles exceptions, and prevents rejections and denials. It will verify coverage before care, generate patient estimates, and handle exceptions with payer calls, policy analysis, and plan carve-out identification. | That eligibility is for sale this week. Early 2027 is the date in the post. |
| Future kits could cover stale claims, contract management, and payment posting. | A date, a commitment, or a customer for those kits. The word in the post is “could.” |
| Bidirectional integrations with the EHR, the clearinghouse, and patient scheduling. Rules handle known cases with no token spend. Agents do payer calls, portal checks, and policy review. Exceptions return to billers in the tool they already use. Audit logs show whether a rule or an agent acted. | A token price, a fee schedule, or which billing system the connection has been proven on. |
| Trusted by over 200 healthcare organizations. Touchless claim rate over 95%, defined as first-pass adjudication with no manual work. Seven years spent building the platform. | That the 95% is an AgentKits yield. Candid attaches the rate, the organization count, and the seven years to the platform. |
| A carve-out walkthrough: a denial that an eligibility check had called covered, a look across plan details, policy, and past adjudications, a payer call if those sources do not settle it, then a rule so the next claim for that pattern routes before submission. | A named organization, a recovered dollar, or a before-and-after. The section is an illustration of the mechanism. |
The touchless rate over 95% is company-reported for the Candid platform, not a result of the Denials AgentKit. About $7 billion in claim volume each year is also company-reported, from CEO Nick Perry’s July Series D post, and it is not a new figure for this launch. The carve-out section names no customer. Eligibility is early 2027. Stale claims, contract management, and payment posting are prospective. No price was disclosed, and none is estimated here.
This is RevCycleAI’s read. The split is the part you can take to a staff meeting. A case that already fits a known pattern is a rule, and Candid says that path spends no tokens. The work that still needs a person on the phone, a portal, or a policy is an agent: payer calls, portal checks, policy review. If the kit cannot close it, the exception returns to your billers in the tool they already open. The audit log is the control. It shows whether a rule or an agent acted, so a denial lead can see which layer touched the claim.
That is a different sale from the denials product R1 put on the market the same day. Phare Denials is one of four Phare OS modules that are commercially available now. Auth, Audit, and UM are the other three. The loop that writes a payer’s reason back into documentation still depends on modules R1 has in early access. Candid is not asking you to move the claim onto its system of record. The kit is built to resolve and prevent the issue inside the billing system the claim already lives in, with a bidirectional connection to the EHR, the clearinghouse, and scheduling. If you are in a renewal with either vendor, the question is whose workqueue the exception lands in.
The numbers that do not travel with the kit are the ones Candid has already published for the platform. Over 95% touchless, over 200 healthcare organizations, seven years. In July, Perry put annual claim volume at about $7 billion, company-reported, in the post that accompanied the $120 million Series D led by Sixth Street Growth. RevCycleAI covered that round on July 22, and covered the Flatiron oncology path as a separate distribution story. Neither is an AgentKits outcome. A rate Candid reports for the platform is not a result for a kit that leaves the billing system where it is.
Eligibility is the kit that would move the check before the visit. Candid says it will confirm coverage, handle the exception, and try to prevent the rejection and the denial: coverage verified before care, a patient estimate, and exceptions worked with payer calls, policy analysis, and plan carve-out identification. Early 2027. The carve-out walkthrough in today’s post is how Candid shows that mechanism on a denial, not a customer result. Future kits could cover stale claims, contract management, and payment posting. Leave those on the roadmap until a post says they are for sale.
Candid is selling a denials kit you can turn on inside the billing system you already run. Rules take the known case, with no token spend. The agent makes the payer call. The exception comes back to your biller, and the audit log says which layer acted. The touchless rate over 95% is the platform’s, company-reported. Eligibility is early 2027. No price and no customer outcome were disclosed, and the carve-out story is an illustration.
Ask where the exception lands, and whether the fee falls when a rule replaces the agent. Denials is the kit on sale today. It investigates, prepares the appeal, handles the write-off, and routes what it cannot finish. Eligibility, the pre-visit check and the patient estimate, is early 2027. Stale claims, contracts, and payment posting are a “could,” not a release. R1 is selling Phare Denials the same day, on Phare OS. The operating difference is whose system the claim lives in.
If you pilot this, the audit log is the document that matters: rule or agent, and why. The 95% does not answer that. Perry’s about $7 billion does not answer it either. Both are company-reported scale for the platform Candid has spent seven years building. The kit is the new object, and it has no yield attached.
What is for sale, what is still a “could,” and whose number the big rate is.
Sources: Candid Health, “Introducing Candid AgentKits: Agentic RCM solutions that eliminate work,” November 12, 2026 (page opened). The item is listed on the Candid newsroom with the same date. The AgentKits product page was opened. Availability, the Denials and Eligibility workflows, the “could” list for later kits, the no-rip-and-replace line, the bidirectional EHR, clearinghouse, and scheduling integrations, the rules-versus-agents split, the exception path, and the audit log are that November 12 post’s. Over 200 healthcare organizations, the touchless claim rate over 95%, the definition of that rate, and the seven years are company-reported in the same post and are attached to the platform. “About $7 billion in claim volume each year” is company-reported from CEO Nick Perry’s July post, “Candid Health raises $120M to automate revenue cycle management.” It is not a new AgentKits figure. The Series D article and the Flatiron article are earlier RevCycleAI stories. The Phare OS article is a separate November 12 launch. The carve-out section of Candid’s post is an illustration, not a named-customer result. No price was disclosed, and none is estimated. The analysis section is RevCycleAI’s read.